Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
12 Apr 2019	Submitted	Original manuscript
23 Jul 2019	Reviewed	Reviewer Report - Juan Yepes
15 Sep 2019	Reviewed	Reviewer Report - Pamela Shaw
12 Oct 2019	Author responded	Author comments - Atsushi Fukunaga
Resubmission - Version 2
12 Oct 2019	Submitted	Manuscript version 2
Publishing
4 Nov 2019	Editorially accepted
6 Jan 2020	Article published	10.1186/s13063-019-3878-2

Back to article page